The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 11 September 2006 doi:10.1084/jem.20061020
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 10, 2239-2245
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2566K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maillard, I.
Right arrow Articles by Pear, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maillard, I.
Right arrow Articles by Pear, W. S.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

BRIEF DEFINITIVE REPORT

The requirement for Notch signaling at the ß-selection checkpoint in vivo is absolute and independent of the pre–T cell receptor

Ivan Maillard1,2, LiLi Tu2,3,4, Arivazhagan Sambandam3, Yumi Yashiro-Ohtani2,3,4, John Millholland2,3,4, Karen Keeshan2,3,4, Olga Shestova2,3,4, Lanwei Xu2,3,4, Avinash Bhandoola3, and Warren S. Pear2,3,4

1 Division of Hematology-Oncology, 2 Abramson Family Cancer Research Institute, 3 Department of Pathology and Laboratory Medicine, and 4 Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA 19104

CORRESPONDENCE Warren S. Pear: wpear{at}mail.med.upenn.edu

Genetic inactivation of Notch signaling in CD4CD8 double-negative (DN) thymocytes was previously shown to impair T cell receptor (TCR) gene rearrangement and to cause a partial block in CD4+CD8+ double-positive (DP) thymocyte development in mice. In contrast, in vitro cultures suggested that Notch was absolutely required for the generation of DP thymocytes independent of pre-TCR expression and activity. To resolve the respective role of Notch and the pre-TCR, we inhibited Notch-mediated transcriptional activation in vivo with a green fluorescent protein–tagged dominant-negative Mastermind-like 1 (DNMAML) that allowed us to track single cells incapable of Notch signaling. DNMAML expression in DN cells led to decreased production of DP thymocytes but only to a modest decrease in intracellular TCRß expression. DNMAML attenuated the pre-TCR–associated increase in cell size and CD27 expression. TCRß or TCR{alpha}ß transgenes failed to rescue DNMAML-related defects. Intrathymic injections of DNMAML or DNMAML+ DN thymocytes revealed a complete DN/DP transition block, with production of DNMAML+ DP thymocytes only from cells undergoing late Notch inactivation. These findings indicate that the Notch requirement during the ß-selection checkpoint in vivo is absolute and independent of the pre-TCR, and it depends on transcriptional activation by Notch via the CSL/RBP-J–MAML complex.


I. Maillard and L. Tu contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Synergy between the pre–T cell receptor and Notch: cementing the {alpha}ß lineage choice
Cynthia J. Guidos
J. Exp. Med. 2006 203: 2233-2237. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS